Neuphoria Therapeutics Inc.
NEUP | NASDAQ
$3.05
$0.00 (0.00%)
Nov 2, 2026, 12:10 PM ET · Market open
TTM Period Ending | Q4 2026 Jun 30, 2026 | Q3 2026 Mar 31, 2026 | Q2 2026 Dec 31, 2025 | Q1 2026 Sep 30, 2025 | Q4 2025 Jun 30, 2025 | Q3 2025 Mar 31, 2025 | Q2 2025 Dec 31, 2024 | Q1 2025 Sep 30, 2024 | Q4 2024 Jun 30, 2024 | Q3 2024 Mar 31, 2024 | Q2 2024 Dec 31, 2023 | Q1 2024 Sep 30, 2023 | Q4 2023 Jun 30, 2023 | Q3 2023 Mar 31, 2023 | Q2 2023 Dec 31, 2022 | Q1 2023 Sep 30, 2022 | Q4 2022 Jun 30, 2022 | Q3 2022 Mar 31, 2022 | Q2 2022 Dec 31, 2021 | Q1 2022 Sep 30, 2021 | Q4 2021 Jun 30, 2021 | Q3 2021 Mar 31, 2021 | Q2 2021 Dec 31, 2020 | Q1 2021 Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.17M | -10.47M | 4.53M | 5.19M | 15.24M | 25.71M | 10.71M | 10.05M | n/a | -66.31K | -132.88K | -66.47K | 16 | 3.01M | 6.01M | 6.03M | 6.05M | 3.27M | 492.34K | 710.04K | 927.8K | 1.41M | 1.89M | 2.44M |
Cost of Revenue | 662.96K | 828.42K | 828.16K | 3.47M | 3.47M | 3.3M | 3.39M | 3.57M | 8.21M | 13.42M | 18.56M | 20.95M | 21.54M | 20.68M | 19.81M | 17.9M | 15.99M | 13.33M | 10.66M | 8.21M | 5.76M | 4.91M | 4.06M | 4.94M |
Gross Profit | 511.21K | -10.97M | 4.2M | 5.02M | 5.02M | 15.33M | 76.14K | -3.57M | -8.21M | -2.74M | 2.85M | 516.25K | -1.27K | -6.89M | -13.79M | -11.87M | -9.94M | -10.05M | -10.17M | -7.5M | -4.83M | -3.5M | -2.17M | -2.5M |
Operating Income | -13.95M | -24.16M | -11.02M | -4.43M | 557.73K | 2.74M | -14.91M | -27.22M | -36.99M | -45.29M | -56.05M | -59.06M | -48.07M | -39.1M | -35.07M | -31.55M | -38.47M | -35.93M | -28.51M | -22.37M | -16.24M | -13.75M | -11.26M | -8.21M |
Interest Income | 665.57K | 582.52K | 409.09K | 272.4K | 166.5K | 105.78K | 174.06K | 223.63K | 322.54K | 448.33K | 518.2K | 528.51K | 484.11K | 331.99K | 181.09K | 90.6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -18.69M | -28.76M | -17.04M | -20.8M | -6.7M | 22.57M | 4.84M | -3.08M | -15.58M | -46.06M | -55.72M | -54.03M | -56.78M | -44.96M | -48.1M | -46.51M | -36.9M | -36.89M | -21.92M | -15.35M | -8.78M | -4.16M | 434.72K | -1.86M |
Net Income | -18.53M | -28.48M | -16.72M | -20.52M | -6.34M | 5.83M | 6.23M | 16.64M | 22.34M | 17.08M | -2.44M | -19.02M | -32.03M | -28.43M | -24.92M | -23.34M | -21.75M | -21.74M | -21.73M | -15.21M | -8.7M | -4.56M | -431.13K | -3.77M |
Selling & General & Admin | 9.63M | 7.18M | 6.14M | 7.2M | 6.83M | 11.67M | 13.1M | 14.26M | 17.61M | 18.64M | 20.37M | 17.05M | 13.35M | 10.18M | 7.05M | 7.36M | 7.66M | 7.67M | 7.68M | 6.66M | 5.64M | 5.34M | 5.04M | 4.94M |
Research & Development | 6.02M | 6.72M | 9.09M | 10.85M | 7.92M | 11.86M | 13.08M | 14.65M | 19.38M | 19.18M | 20.72M | 21.73M | 19.58M | 19.67M | 19.81M | 17.9M | 15.99M | 13.33M | 10.66M | 8.21M | 5.76M | 4.91M | 4.06M | 4.94M |
Other Expenses | -3.76M | 16.76B | 16.77B | 16.76B | 16.76B | -7.26M | -9.25M | -9.67M | -7.82M | -3.07M | 956.69K | 4.06M | 4.06M | 2.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 11.89M | 16.78B | 16.78B | 16.78B | 16.78B | 16.27M | 16.93M | 19.24M | 29.17M | 34.75M | 42.04M | 42.84M | 36.99M | 31.89M | 26.86M | 25.26M | 23.65M | 20.99M | 18.34M | 14.87M | 11.41M | 10.25M | 9.1M | 9.88M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.89K | 3.77K | 10.38K | 16.99K | 486.42K | 955.33K | 1.19M | 1.42M | 1.48M | 1.54M | 1.3M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 16.12K | -80.64K | -31.11K | -31.11K | -47.23K | -5.98K | -111.23K | -55.64K | 9.40 | 103.31K | 206.81K | 234.61K | 262.3K | 512.3K | 761.99K | 1.02M | 1.27M | 1.29M | 1.31M | 1.24M |
Cost & Expenses | 12.22M | 16.78B | 16.78B | 16.78B | 16.78B | 16.44M | 17.1M | 19.4M | 24.38M | 35.33M | 48.01M | 54.2M | 58.53M | 52.57M | 46.66M | 43.16M | 39.64M | 34.32M | 29M | 23.08M | 17.17M | 15.16M | 13.15M | 14.82M |
Income Tax Expense | -157.02K | -279.07K | -325.47K | -279.06K | -358.61K | -167.65K | -47.61K | -133.94K | -86.63K | -434.29K | -786.7K | -763.96K | -627.04K | -361.82K | 54 | 4.5K | -95.06K | -293.66K | -588.43K | -492.51K | -396.88K | -95.42K | 206.27K | 207.08K |
Shares Outstanding (Basic) | 5.41M | 5.41M | 4.54M | 2.25M | 1.62M | 234.01M | 234.01M | 234.01M | 92M | 143.52M | 137.23M | 124.67M | 1.59B | 1.59B | 1.35B | 1.35B | 1.06B | 1.06B | 1B | 1B | 1.01B | 1.01B | 735.25M | 735.25M |
Shares Outstanding (Diluted) | 5.41M | 5.41M | 4.54M | 2.25M | 1.62M | 234.01M | 234.01M | 234.01M | 92M | 143.52M | 137.23M | 124.67M | 1.59B | 1.59B | 1.35B | 1.35B | 1.7B | 1.7B | 1B | 1B | 1.01B | 1.01B | 735.25M | 735.25M |
EPS (Basic) | -7.26 | -11 | -4.36 | -4.78 | 1.89 | 6.53 | -0.05 | -0.09 | -0.13 | -0.13 | -0.10 | -0.06 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | 0 | 0 | 0 |
EPS (Diluted) | -7.26 | -11 | -4.36 | -4.78 | 1.89 | 6.53 | -0.05 | -0.09 | -0.13 | -0.13 | -0.10 | -0.06 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | 0 | 0 | 0 |
EBITDA | -12.57M | -22.73M | -9.59M | -11.55M | -8.26M | -6.05M | -23.47M | -27.47M | -35.39M | -35.96M | -39.14M | -37.1M | -31.36M | -25.6M | -19.92M | -18.29M | -16.65M | -16.73M | -16.68M | -12.83M | -8.98M | -7.17M | -5.48M | -5.77M |
EBIT | -13.4M | -23.62M | -10.47M | -4.43M | -1.13M | 1.05M | -16.6M | -28.71M | -31.99M | -32.57M | -35.58M | -33.42M | -32.3M | -26.53M | -20.84M | -19.22M | -17.59M | -17.66M | -17.74M | -14M | -10.28M | -8.59M | -6.9M | -7.19M |
Depreciation & Amortization | 830.57K | 883.39K | 883.12K | 903.11K | 896.34K | 925.89K | 1.15M | 1.24M | 1.4M | 1.4M | 1.24M | 1.12M | 943.03K | 925.15K | 927.78K | 931.14K | 934.08K | 937.82K | 1.06M | 1.18M | 1.3M | 1.42M | 1.42M | 1.43M |
Add to Watchlist
Select watchlists to add or remove NEUP